Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Racheal Rowles"'
Publikováno v:
Journal of clinical psychopharmacology. 40(2)
Purpose/background Daridorexant is a dual orexin receptor antagonist in development for the treatment of sleep disorders. Thus far, it has not yet been studied in Japanese subjects. Study objectives were to evaluate the pharmacokinetics (PK), pharmac
Autor:
Michael Antoniou, Sophia Aristodemou, Alain Hovnanian, Christos Georgiadis, Mei Chen, Su M. Lwin, M. Titeux, S. Miskinyte, Rashida Pramanik, Waseem Qasim, Lucas Chan, Rachel Phillips, Jakub Tolar, Wei Li Di, John A. McGrath, Adrian J. Thrasher, Christos Tziotzios, Linda Ozoemena, Alyson Guy, Alya Abdul-Wahab, Fiona Reid, James R. McMillan, Magdalena Martinez-Queipo, Lu Liu, Fernando Larcher, Jemima E. Mellerio, Johann W. Bauer, Patricia A. Lovell, Marcela Del Rio, Sonia Serrano, Clarisse Maurin, Anastasia Petrova, Farhatullah Syed, Alexandros Onoufriadis, Tendai Kadiyirire, Ellie Rashidghamat, Maria Elstad, Racheal Rowles, Farzin Farzaneh, John B. Mee, Elizabeth Orrin
BACKGROUND: Recessive dystrophic epidermolysis bullosa (RDEB) is a severe form of skin fragility disorder due to mutations in COL7A1 encoding basement membrane type VII collagen (C7), the main constituent of anchoring fibrils (AFs) in skin. We develo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3df16e09632564610c72d70991aa6380
http://hdl.handle.net/10044/1/74451
http://hdl.handle.net/10044/1/74451